(Q33839180)

29 July 2017

1 reference

title

Multidisciplinary management of recurrent colorectal cancer (English)

1 reference

recurrent colorectal cancer

29 July 2017

1 reference

1 reference

1 reference

Miller AR

1

1 reference

29 July 2017

publication date

1 November 1998

1 reference

29 July 2017

1 reference

29 July 2017

volume

7

1 reference

29 July 2017

issue

3-4

1 reference

29 July 2017

page(s)

209-221

1 reference

Effective surgical adjuvant therapy for high-risk rectal carcinoma

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Pelvic exenteration for recurrent colorectal carcinoma: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Preoperative infusional chemoradiation, selective intraoperative radiation, and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Palliative operations for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Factors influencing local recurrence after abdominoperineal resection for cancer of the rectum and rectosigmoid

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Multivariate analysis of recurrence after anterior resection for colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Regression analysis of prognostic factors in colorectal cancer after curative resections

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Importance of tumor pathology and morphology in patients with surgically resected colon cancer. Findings from the Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Peculiarities of mucinous colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

The clinical significance of invasion of veins by rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

The prognostic significance of p53 expression for survival and local control in rectal carcinoma treated with surgery and postoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Surgical management of locally recurrent rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Rate and treatment of pelvic recurrence after abdominoperineal resection and low anterior resection for rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

An analysis of survival and treatment failure following abdominoperineal and sphincter-saving resection in Dukes' B and C rectal carcinoma. A report of the NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Carcinoma of the rectum: a 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Local recurrence following abdominoperineal excision and anterior resection for rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Anastomotic recurrences after low anterior resection. Stapled vs. hand-sewn

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Recurrence of colorectal cancer after sutured and stapled large bowel anastomoses

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Total mesorectal excision--the new golden standard of surgery for rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Mesorectal excision for rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Changing strategy for rectal cancer is associated with improved outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Prolongation of the disease-free interval in surgically treated rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Randomized trials of adjuvant radiation therapy for rectal carcinoma: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Follow-Up of Patients with Colorectal Cancer A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Detection of recurrence after surgery for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Salvage therapy for pelvic recurrence following curative rectal cancer resection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Aggressive surgical management of recurrent rectal cancer--is it worthwhile?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Colorectal cancer. Diagnosis of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Value of outpatient follow-up after curative surgery for carcinoma of the large bowel.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Treatment of local recurrence of rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Curative reoperations for locally recurrent rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

The use of computed tomography in recurrent rectal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Value of Computed Tomography in the Detection and Staging of Recurrent Rectal Carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Preoperative and postoperative CT staging of rectosigmoid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Colorectal carcinoma evaluation with CT: preoperative staging and detection of postoperative recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Recurrent colorectal carcinoma: evaluation with barium enema examination and CT

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Colorectal cancer: cross-sectional imaging for staging of primary tumor and detection of local recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Staging rectal cancer by MR and CT

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Recurrent rectal cancer: diagnosis with dynamic MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

MR Imaging, CT and CEA Scintigraphy in the Diagnosis of Local Recurrence of Rectal Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Tumor recurrence versus fibrosis in the female pelvis: differentiation with MR imaging at 1.5 T

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

MR imaging of recurrent colorectal carcinoma versus fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Prospective comparative study of magnetic resonance imaging versus transrectal ultrasound for preoperative staging and follow-up of rectal cancer. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Evaluation and biopsy of recurrent rectal cancer using three-dimensional endosonography

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

The detection and evaluation of locally recurrent rectal cancer with rectal endosonography

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Endoscopic ultrasound and endorectal magnetic resonance imaging: a prospective, comparative study for preoperative staging and follow-up of rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Endoluminal ultrasound for early detection of local recurrence of rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Impact of computed tomography vs. intrarectal ultrasound on the diagnosis, resectability, and prognosis of locally recurrent rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

MRI diagnosis and staging of rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Three-dimensional endosonography for staging of rectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

New diagnostic imaging in rectal cancer: endosonography and immunoscintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Recurrence of colorectal tumors: PET evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Immediate reconstruction of the perineal wound with gracilis muscle flaps following abdominoperineal resection and intraoperative radiation therapy for recurrent carcinoma of the rectum

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Significance of local recurrence of rectal cancer as a local or disseminated disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Prognostic factors in surgery for local recurrence of rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Pelvic Resection of Recurrent Rectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Pelvic exenteration and its modifications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Radical surgery for extensive rectal cancer: is it worthwhile?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Pilot study evaluating the intraoperative localization of radiolabeled monoclonal antibody CC83 in patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Radioimmunoguided Surgery system improves survival for patients with recurrent colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Curative surgical resection following reirradiation for recurrent rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Palliative reirradiation for recurrent rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

The incidence and clinical consequences of treatment-related bowel injury

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Use of brachytherapy in management of locally recurrent rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose-response analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

A phase I/II study of intraoperative radiotherapy in advanced unresectable or recurrent carcinoma of the rectum: a Radiation Therapy Oncology Group (RTOG) study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Intraoperative radiotherapy in locally advanced recurrent colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Combined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Radiochemotherapy and hyperthermia in the treatment of rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Chemotherapy for the treatment of patients with metastatic colorectal cancer: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

National Cancer Institute Clinical Trials Program in Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900019-5

7 January 2021

10.1016/S0960-7404(99)00019-5

Identifiers

DOI

1 reference

29 July 2017

1 reference